Pharmaceutical / Drug Definition :
Converts paroxysmal supraventricular tachycardia (PSVT) to normal sinus rhythm by slowing conduction through atrioventricular (AV) node and interrupting reentry pathway. Also used as a diagnostic agent in thallium scanning.
In the United States, Adenosine is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Adenosine.
Registrar Corp assists Adenosine companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Adenosine (Adenosine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Adenosine (Adenosine Suppliers)
- Processors Adenosine
- Repackers Adenosine
- Relabelers Adenosine
- Exporters Adenosine
- Importers Adenosine
For more information about Adenosine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.